How many drugs treat Giardiasis?

Drug Landscape tracks 5 marketed treatments for Giardiasis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/giardiasis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Giardiasis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Giardiasis (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Giardiasis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Solosec	SECNIDAZOLE	Evofem Inc	Nitroimidazole Antimicrobial [EPC]		2017-01-01
Tindamax	TINIDAZOLE	Mission Pharma	Nitroimidazole Antimicrobial [EPC]		2004-01-01
Alinia	NITAZOXANIDE	Romark	Antiprotozoal [EPC]	Anoctamin-1	2002-01-01
Metro I.V. In Plastic Container	METRONIDAZOLE	Baxter	Nitroimidazole Antimicrobial [EPC]		1963-01-01
Metronidazol	Metronidazol	University of Oslo		Thioredoxin reductase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Giardiasis
Baxter · 1 drug in Giardiasis
Evofem Inc · 1 drug in Giardiasis
Mission Pharma · 1 drug in Giardiasis
Romark · 1 drug in Giardiasis
University of Oslo · 1 drug in Giardiasis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Giardiasis:

Cite this brief

Drug Landscape (2026). Giardiasis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/giardiasis. Accessed 2026-06-10.

Giardiasis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing